BiospaceHealth

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference

Vericel Corporation announced it will present at the 24th Annual Morgan Stanley Global Healthcare Conference on September 15, 2026. A webcast of the presentation will be available on the company's website.

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference

Automatically summarised by AI from Biospace

BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) – Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced that the Company will present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026. A webcast of the presentation will be available on the Investor Relations section of the company's website.

Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets, combining innovations in biology with medical technologies to offer a portfolio of cell therapies and specialty biologics. The Company currently markets three products in the United States, including MACI® and Epicel®, and holds an exclusive license for North American rights to NexoBrid®.

Epicel®, MACI® and MACI Arthro® are registered trademarks of Vericel Corporation. NexoBrid® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation.

Health · Biospace · Published 21:09 · 08 Sept 2026

Read the original ↗

Related stories

Democratic AccentHealth

During a taping of Oprah Winfrey's podcast, the audience applauded a call by guest Dr. Kameelah Phillips to support women of color who lack the privilege and resources of Lindsay Clancy. The discussion followed a mistrial in Clancy's case, where she was accused of killing her three children while her defense argued she suffered from postpartum psychosis.